Mizuho Financial Group Inc Stock News

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Corvus Pharmaceuticals (CRVS) yesterday and set a price target of $7.00. The company's

Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Corvus Pharmaceuticals ( CRVS – Research Report ) yesterday and set a price target of $7.00 . The company’s shares closed last T

Q1 2020 Novocure Ltd Earnings Call

Full Year 2020 SBI Holdings Inc Earnings Presentation

Citigroup upgraded shares of Quest Diagnostics (NYSE:DGX) from a neutral rating to a buy rating in a research note released on Monday morning, Benzinga reports. The brokerage currently has $130.00 pri

Beirne Wealth Consulting Services LLC increased its holdings in shares of Alphabet Inc (NASDAQ:GOOG) by 2.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchang

1ST Source Bank raised its position in shares of AbbVie Inc (NYSE:ABBV) by 8.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The

Cottage Street Advisors LLC lowered its stake in shares of Applied Materials, Inc. (NASDAQ:AMAT) by 10.5% in the first quarter, according to the company in its most recent filing with the Securities a

Crossmark Global Holdings Inc. decreased its position in Booking Holdings Inc. (NASDAQ:BKNG) by 10.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and

Wolfe Research upgraded shares of Laboratory Corp. of America (NYSE:LH) from an underperform rating to a market perform rating in a research report report published on Monday, Briefing.com Automated I

Sarepta Therapeutics (NASDAQ:SRPT)‘s stock had its “buy” rating reissued by equities research analysts at Mizuho in a research note issued on Thursday, AnalystRatings.com reports. They currently

Cwm LLC trimmed its holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 4.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission

Crossmark Global Holdings Inc. lowered its position in shares of LTC Properties Inc (NYSE:LTC) by 2.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange

Calamos Wealth Management LLC lowered its holdings in Texas Instruments Incorporated (NASDAQ:TXN) by 12.9% in the first quarter, according to its most recent disclosure with the SEC. The institutional

1ST Source Bank cut its holdings in shares of Eli Lilly And Co (NYSE:LLY) by 1.4% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owne